DE69432015T2 - Verfahren - Google Patents
VerfahrenInfo
- Publication number
- DE69432015T2 DE69432015T2 DE69432015T DE69432015T DE69432015T2 DE 69432015 T2 DE69432015 T2 DE 69432015T2 DE 69432015 T DE69432015 T DE 69432015T DE 69432015 T DE69432015 T DE 69432015T DE 69432015 T2 DE69432015 T2 DE 69432015T2
- Authority
- DE
- Germany
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939311188A GB9311188D0 (en) | 1993-05-29 | 1993-05-29 | Process |
GB939316252A GB9316252D0 (en) | 1993-08-05 | 1993-08-05 | Process |
GB939318920A GB9318920D0 (en) | 1993-09-11 | 1993-09-11 | Process |
PCT/US1994/005930 WO1994027557A2 (en) | 1993-05-29 | 1994-05-26 | Pharmaceutical thermal infusion process |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69432015D1 DE69432015D1 (de) | 2003-02-20 |
DE69432015T2 true DE69432015T2 (de) | 2003-11-06 |
Family
ID=27266706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69432015T Expired - Fee Related DE69432015T2 (de) | 1993-05-29 | 1994-05-26 | Verfahren |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0701436B1 (de) |
JP (1) | JPH08510752A (de) |
CN (1) | CN1124452A (de) |
AP (1) | AP9400645A0 (de) |
AT (1) | ATE230981T1 (de) |
AU (1) | AU684522B2 (de) |
CA (1) | CA2164003A1 (de) |
DE (1) | DE69432015T2 (de) |
ES (1) | ES2189803T3 (de) |
IL (1) | IL109770A0 (de) |
MA (1) | MA23212A1 (de) |
NZ (1) | NZ268172A (de) |
WO (1) | WO1994027557A2 (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9402203D0 (en) * | 1994-02-04 | 1994-03-30 | Smithkline Beecham Plc | Pharmaceutical formulation |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
GB9416600D0 (en) * | 1994-08-17 | 1994-10-12 | Smithkline Beecham Plc | Pharmaceutical formulation |
CN1289084C (zh) * | 1995-09-07 | 2006-12-13 | 史密丝克莱恩比彻姆有限公司 | 药物制剂 |
TWI225402B (en) | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
AT407701B (de) * | 1996-08-12 | 2001-05-25 | Biochemie Gmbh | Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung |
FR2753904B1 (fr) | 1996-10-01 | 1998-10-30 | Gattefosse Ets Sa | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
IL119627A (en) * | 1996-11-17 | 2002-03-10 | Yissum Res Dev Co | PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT |
CN1194687C (zh) * | 1997-02-14 | 2005-03-30 | 史密斯克莱恩比彻姆药物实验室 | 含有阿莫西林和克拉维酸盐的药物制剂 |
DE19705538C1 (de) * | 1997-02-14 | 1998-08-27 | Goedecke Ag | Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen |
ATE286721T1 (de) * | 1997-09-19 | 2005-01-15 | Shire Lab Inc | Feste lösungskügelchen |
WO1999017751A1 (en) * | 1997-10-03 | 1999-04-15 | Smithkline Beecham Corporation | Controlled release solid dosage forms of lithium carbonate |
PL334517A1 (en) * | 1997-11-17 | 2000-02-28 | Gist Brocades Bv | Clavulate and one or more of exicipients containing granules |
ES2412409T3 (es) * | 1997-12-22 | 2013-07-11 | Euro-Celtique S.A. | Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo |
NZ506202A (en) | 1998-03-19 | 2003-10-31 | Bristol Myers Squibb Co | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
US6878386B1 (en) | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
DK200000133U3 (da) * | 1999-04-13 | 2000-07-28 | Beecham Pharm Pte Ltd | Ny farmaceutisk formulering |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6627222B2 (en) | 2000-02-24 | 2003-09-30 | Advancis Pharmaceutical Corp. | Amoxicillin-dicloxacillin antibiotic composition |
US6632453B2 (en) | 2000-02-24 | 2003-10-14 | Advancis Pharmaceutical Corp. | Ciprofoxacin-metronidazole antibiotic composition |
US6669948B2 (en) | 2000-02-24 | 2003-12-30 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6667057B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Levofloxacin antibiotic product, use and formulation thereof |
US6663891B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Erythromyacin antibiotic product, use and formulation thereof |
JP2003523372A (ja) | 2000-02-24 | 2003-08-05 | アドバンシス ファーマシューティカル コーポレイション | 抗生物質及び抗真菌剤組成物 |
US6610328B2 (en) | 2000-02-24 | 2003-08-26 | Advancis Pharmaceutical Corp. | Amoxicillin-clarithromycin antibiotic composition |
WO2001062231A1 (en) * | 2000-02-24 | 2001-08-30 | Advancis Pharmaceutical Corporation | Antibiotic composition with inhibitor |
US6623758B2 (en) | 2000-02-24 | 2003-09-23 | Advancis Pharmaceutical Corp. | Cephalosporin-metronidazole antibiotic composition |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6991807B2 (en) | 2000-02-24 | 2006-01-31 | Advancis Pharmaceutical, Corp. | Antibiotic composition |
US6663890B2 (en) | 2000-02-24 | 2003-12-16 | Advancis Pharmaceutical Corp. | Metronidazole antibiotic product, use and formulation thereof |
US6730320B2 (en) | 2000-02-24 | 2004-05-04 | Advancis Pharmaceutical Corp. | Tetracycline antibiotic product, use and formulation thereof |
US6667042B2 (en) | 2000-02-24 | 2003-12-23 | Advancis Pharmaceutical Corp. | Fluroquinilone antibiotic product, use and formulation thereof |
US7025989B2 (en) | 2000-02-24 | 2006-04-11 | Advancis Pharmaceutical Corp. | Multiple-delayed released antibiotic product, use and formulation thereof |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US7985420B2 (en) | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US8012504B2 (en) | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US7838032B2 (en) | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
AU2001292185A1 (en) | 2000-10-12 | 2002-04-22 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US7157095B2 (en) | 2000-10-13 | 2007-01-02 | Advancis Pharmaceutical Corporation | Multiple-delayed release antifungal product, use and formulation thereof |
US7074417B2 (en) | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
US7105174B2 (en) | 2000-10-13 | 2006-09-12 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-neoplastic product, use and formulation thereof |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020197314A1 (en) | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
AT413015B (de) * | 2001-04-12 | 2005-10-15 | Sandoz Ag | Tablette enthaltend das k-salz der 3-(2-hydroxyethyliden)-7-oxo-4-oxa-1- azabicyclo(3.2.0)heptan-2 carbonsäure in hydrophobisierter form |
GB0209265D0 (en) * | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
EP1599189A4 (de) * | 2003-03-04 | 2009-07-01 | Nostrum Pharmaceuticals Inc | Formulierung mit gesteuerter freisetzung und mit wasserabweisendem material als mittel für die verzögerte freisetzung |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
JP2007513143A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 押出機を使用して好ましくはポロクサマーおよびグリセリドを含む多粒子アジスロマイシン組成物を製造するための噴霧凝固法 |
BRPI0417348A (pt) * | 2003-12-04 | 2007-03-13 | Pfizer Prod Inc | processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo |
PE20060652A1 (es) * | 2004-08-27 | 2006-08-11 | Novartis Ag | Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion |
KR101214665B1 (ko) | 2004-09-16 | 2012-12-21 | 아스텔라스세이야쿠 가부시키가이샤 | 트리아졸 유도체 또는 그의 염 |
CN103153288B (zh) | 2010-07-09 | 2017-02-15 | 詹姆斯·特林卡·格林 | 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统 |
GB201420306D0 (en) | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Compositions |
GB201420311D0 (en) * | 2014-11-14 | 2014-12-31 | Bio Images Drug Delivery Ltd | Pharmaceutical processing |
US11278506B2 (en) | 2015-10-09 | 2022-03-22 | Rb Health (Us) Llc | Pharmaceutical formulation |
EP3994154A1 (de) | 2019-07-05 | 2022-05-11 | GlaxoSmithKline Intellectual Property (No.2) Limited | Streptomyces clavuligerus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4132753A (en) * | 1965-02-12 | 1979-01-02 | American Cyanamid Company | Process for preparing oral sustained release granules |
JPS56140915A (en) * | 1980-04-07 | 1981-11-04 | Yamanouchi Pharmaceut Co Ltd | Pharmaceutical preparation for solid drug |
US5169645A (en) * | 1989-10-31 | 1992-12-08 | Duquesne University Of The Holy Ghost | Directly compressible granules having improved flow properties |
-
1994
- 1994-05-25 IL IL10977094A patent/IL109770A0/xx unknown
- 1994-05-26 CA CA002164003A patent/CA2164003A1/en not_active Abandoned
- 1994-05-26 DE DE69432015T patent/DE69432015T2/de not_active Expired - Fee Related
- 1994-05-26 AT AT94920040T patent/ATE230981T1/de not_active IP Right Cessation
- 1994-05-26 EP EP94920040A patent/EP0701436B1/de not_active Expired - Lifetime
- 1994-05-26 NZ NZ268172A patent/NZ268172A/en unknown
- 1994-05-26 AP APAP/P/1994/000645A patent/AP9400645A0/en unknown
- 1994-05-26 JP JP7500960A patent/JPH08510752A/ja active Pending
- 1994-05-26 AU AU70962/94A patent/AU684522B2/en not_active Ceased
- 1994-05-26 WO PCT/US1994/005930 patent/WO1994027557A2/en active IP Right Grant
- 1994-05-26 ES ES94920040T patent/ES2189803T3/es not_active Expired - Lifetime
- 1994-05-26 CN CN94192262A patent/CN1124452A/zh active Pending
- 1994-05-27 MA MA23523A patent/MA23212A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
AU684522B2 (en) | 1997-12-18 |
WO1994027557A2 (en) | 1994-12-08 |
AU7096294A (en) | 1994-12-20 |
WO1994027557A3 (en) | 1995-03-16 |
CN1124452A (zh) | 1996-06-12 |
NZ268172A (en) | 1997-12-19 |
ATE230981T1 (de) | 2003-02-15 |
CA2164003A1 (en) | 1994-12-08 |
ES2189803T3 (es) | 2003-07-16 |
MA23212A1 (fr) | 1994-12-31 |
EP0701436B1 (de) | 2003-01-15 |
EP0701436A4 (de) | 1997-05-21 |
JPH08510752A (ja) | 1996-11-12 |
IL109770A0 (en) | 1994-11-28 |
EP0701436A1 (de) | 1996-03-20 |
DE69432015D1 (de) | 2003-02-20 |
AP9400645A0 (en) | 1994-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69432015D1 (de) | Verfahren | |
FI956135A0 (fi) | Erotusmenetelmä | |
DE69414001D1 (de) | Bestimmungsmethode | |
DE69420250D1 (de) | Verbessertes verfahren zur nachhallunterdrückung | |
DE69327454D1 (de) | Analytisches verfahren | |
FI945507A0 (fi) | Monikäyttömenetelmä | |
DE69227201D1 (de) | Spektroskopisches Verfahren | |
DE69425761T2 (de) | Topographisches Verfahren | |
NO921218D0 (no) | Reseptor-rensemetode | |
NO307247B1 (no) | Sveisemetode | |
DE69406945D1 (de) | Katalytisches verfahren | |
DE69428364D1 (de) | Verfahren zur brandbekämpfung | |
DE69430338D1 (de) | Verfahren zur Spectrometrie | |
DE69423875T2 (de) | Hydrodealkylierungsverfahren | |
DK96392D0 (da) | Modifikationsmetode | |
NO308345B1 (no) | Sveisemetode | |
FI933682A0 (fi) | Metod foer att producera transgena saedesvaexter | |
DE69408437T2 (de) | Oxychlorierungsverfahren | |
DE69418320T2 (de) | Verfahren zur rückgewinnung von fluorwasserstoff | |
BR9407815A (pt) | Método de ensaio | |
FI931051A (fi) | Kuvausmenetelmä | |
FI961633A (fi) | Puhdistusmenetelmä | |
DK44493D0 (da) | Improved method | |
DK138893D0 (da) | Improved method | |
FI934745A0 (fi) | Metod styra elstroem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |